Navigation Links
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Date:5/19/2008

- Conference call scheduled to discuss Shionogi Phase 3 results on

pirfenidone -

BRISBANE, Calif., May 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that its program for the development of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA). Fast Track is a designation that the FDA reserves for a drug intended to treat a serious or life threatening condition and one that demonstrates the potential to address an unmet medical need for the condition. The FDA takes appropriate actions to facilitate the development and expedite the review of the approval applications for fast track products.

Dan Welch, Chairman and Chief Executive Officer of InterMune, said, "There are no approved medicines to treat patients who suffer from IPF, a uniformly fatal disease characterized by scarring and inflammation of the lungs. The FDA's action in granting fast track designation is an indication of pirfenidone's potential to address this serious, unmet medical need. We look forward to reporting top-line results of our Phase 3 CAPACITY program of pirfenidone in IPF, in January of 2009."

Webcast and Conference Call on May 20, 5:00 p.m. EDT

InterMune additionally announced that it will conduct a live webcast and conference call on May 20, 2008 at 5:00 p.m. EDT to discuss its Phase 3 CAPACITY program in the context of data that will be presented by Shionogi & Co., Ltd. regarding its Phase 3 trial of pirfenidone in Japan. The Shionogi Phase 3 results are scheduled to be reported in an oral presentation at the meeting of the American Thoracic Society in Toronto at 2:15 p.m.
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune Announces Progress on Pirfenidone in IPF
2. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Announces Start of Phase 1b Trial of ITMN-191
5. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
6. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
7. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
8. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
9. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
10. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
11. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Research and Markets  has announced the addition of ... Global Forecast to 2019" report to their offering. ... equipment market is categorized on the basis of product ... expected to register the highest growth rate in the ... 2019). This high growth is attributed to the rising ...
(Date:10/25/2014)... 2014 Research and Markets ... the "Global and Chinese Hemodialysis Concentrates Industry ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , Global ... a professional and in-depth study on the current ... focus on the Chinese situation. The ...
(Date:10/25/2014)... , Oct. 24, 2014 In conjunction ... quarter 2014 financial results press release, you are invited ... broadcast live over the internet on Monday, November 3, ... Time). A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations."  If you ...
Breaking Medicine Technology:Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
... Ind., Feb. 24, 2011 Symmetry Medical Inc. (NYSE: ... orthopaedic device industry and other medical markets, announced fourth quarter and ... 2011.Fourth QuarterTotal Year (In millions, except per share data) , ... 96.0 , $ 76.4 , 26%$ 360.8 , $ 365.9 , ...
... Mass. and SYDNEY, Feb. 24, 2011 HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced revenues of $20.9 million for the fourth ... million in revenues for the fourth quarter of 2009, ...
Cached Medicine Technology:Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 2Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 3Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 4Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 5Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 6Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 7Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 8Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 9HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 2HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 3HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 4HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 5HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 6
(Date:10/22/2014)... OR (PRWEB) October 22, 2014 During ... California’s fresh water supply runs dangerously low, Southern Oregon’s ... Southern Oregon’s rivers, despite the lowest mountain snow pack ... in late summer and early autumn.* That was the ... of the new book “Hiking Southern Oregon,” during an ...
(Date:10/22/2014)... 2014 Healthcare professionals who are ... education at home or on-the-go via laptops, tablets ... brand new, premium Seminar-on-Demand CE courses. The new ... 2,000 hours of CE course offerings, ... experience. With such a diverse library, there’s something ...
(Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
(Date:10/22/2014)... of Prussia, PA (PRWEB) October 22, 2014 ... is recognized as an industry leader with over 25 ... award winning team leader in the areas related to ... addition, Mr. Carlson is an Editorial Advisory Board member ... Healthcare Council Educator. Blue Fin Group is a ...
(Date:10/22/2014)... By Steven Reinberg ... -- Infants who quickly add weight and length may be ... study suggests. In adults, certain genes have been linked ... promote proportionate gains in fat and lean muscle, the researchers ... be heavier and taller. By ages 2 and 3, however, ...
Breaking Medicine News(10 mins):Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2
... of twins and their mothers to see if there was ... years // of life and children's antisocial behavior by age ... to have increased problems with conduct and more antisocial behavior ... after the twins' birth and the likeliness of antisocial behavior ...
... California School of Dentistry has devised a test to predict ... to measure the relative concentration of various sugar chains called ... as those present in the teeth surface. Some sugar chains ... bacteria to bond with the tooth. Each individual sugar chain ...
... have shown that oral examination may not foretell much ... Earlier patients suffering from obstructive sleep apnea syndrome ... sleep. And so snoring was known as one of ... as the condition of fragmented sleep is associated with ...
... According to latest research rheumatoid arthritis patients have twice ... the heart's ability // to pump blood, compared to ... study showed patients with rheumatoid arthritis are at an ... of arthritis, and this risk continues throughout the course ...
... by Northwestern University about the effects of epidural pain relief ... at the early stages of labor does not increase the ... final term were observed for the study. All were delivering ... were given epidural in the early stages of labor tended ...
... found a herb used in traditional Indian medicine to ... levels // in a manner similar to prescription drugs. ... called salacia oblonga, which is native to regions of ... enzymes that break down carbohydrates in the body. These ...
Cached Medicine News:
... a comprehensive, authoritative drug reference to ... overdose management, Canadian drug names, OTC ... drug references and tools is included ... (ED, PRIMARY CARE PLUS, CRC, RN, ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
... the latest in scientific clinical trial activity ... knowledge resources from CenterWatch. This highly valuable ... monitor and stay abreast of medical breakthroughs ... Clinical Trials, Clinical Trial Results, Newly Approved ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: